Cervical cancer is the fourth most frequently occurring cancer in women around the world
and can affect them during their reproductive years. Since the development of the …

Background Modelling studies have been widely used to inform human papillomavirus
(HPV) vaccination policy decisions; however, many models exist and it is not known whether …

Aktuelle und belastbare Daten zum Impfstatus der Bevölkerung sind für die
zielgruppenspezifische Kommunikation zu Impfungen und zur Evaluation von …

Background Adequate coverage is key to the success of human papillomavirus (HPV)
vaccination programmes. There is currently no organised HPV vaccination programme in …

Human papillomaviruses (HPV) are widespread DNA viruses that can infect epithelial cells
of the skin and mucosa. Most HPV infections remain clinically unapparent and clear …

Cervical cancer (CC) is second most common cause of cancer in Latin America and is a
leading cause of cancer mortality among women. In 2015, an estimated 74,488 women will …

Background The aim of this study was to assess the cost-effectiveness of human
papillomavirus (HPV) vaccination in addition to the current cervical cancer screening …

ABSTRACT Introduction: Since 2007, the German Standing Vaccination Committee
recommends HPV vaccination for girls aged 12–17 with a 2-(Cervarix®) or 4-valent …

Background There have not been any population-based surveys in Germany to date on the
frequency of various types of sexual behavior. The topic is of interdisciplinary interest …

Vaccination is effective in preventing human papillomavirus (HPV) infection. It still remains
debatable whether males should be included in a vaccination program and unclear how to …